Literature DB >> 15128955

Atypical antipsychotic dosing: the effect of smoking and caffeine.

Jose de Leon1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128955     DOI: 10.1176/appi.ps.55.5.491

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


× No keyword cloud information.
  19 in total

Review 1.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Smoking cessation in patients with psychiatric disorders.

Authors:  Alan J Gelenberg; Jose de Leon; A Eden Evins; Joseph J Parks; Nancy A Rigotti
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 3.  Pharmacogenetics in psychiatry: are we ready for widespread clinical use?

Authors:  Maria J Arranz; Shitij Kapur
Journal:  Schizophr Bull       Date:  2008-08-27       Impact factor: 9.306

4.  A Reasonable Alternative to Clozapine in the Chronically Relapsing Smoking Patient? A Retrospective Analysis.

Authors:  John R Tomko; Nadeem Ahmed; Cynthia Kuntz; Justine Zick
Journal:  Hosp Pharm       Date:  2016-11

5.  Depression and Cognitive Impairment Are Associated with Low Education and Literacy Status and Smoking but Not Caffeine Consumption in Urban African Americans and White Adults.

Authors:  Andrew V Kuczmarski; Nancy Cotugna; Marc A Mason; Michele K Evans; Alan B Zonderman
Journal:  J Caffeine Res       Date:  2015-03-01

6.  Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.

Authors:  Karolina Kozak; Tony P George
Journal:  Expert Opin Pharmacother       Date:  2020-02-03       Impact factor: 3.889

7.  Sialorrhea and aspiration pneumonia: a case study.

Authors:  Eileen Trigoboff; Jeffery Grace; Herman Szymanski; Jaspinder Bhullar; Claudia Lee; Thomas Watson
Journal:  Innov Clin Neurosci       Date:  2013-05

8.  A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.

Authors:  Tony P George; Jennifer C Vessicchio; Kristi A Sacco; Andrea H Weinberger; Melissa M Dudas; Taryn M Allen; Cerissa L Creeden; Marc N Potenza; Alan Feingold; Peter I Jatlow
Journal:  Biol Psychiatry       Date:  2007-12-21       Impact factor: 13.382

Review 9.  [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].

Authors:  H Javelot; P-M Llorca; D Drapier; E Fakra; C Hingray; G Meyer; S Dizet; A Egron; C Straczek; M Roser; M Masson; R Gaillard; P Fossati; E Haffen
Journal:  Encephale       Date:  2020-05-04       Impact factor: 1.291

Review 10.  Treatment of tobacco dependence in mental health and addictive disorders.

Authors:  Brian Hitsman; Taryn G Moss; Ivan D Montoya; Tony P George
Journal:  Can J Psychiatry       Date:  2009-06       Impact factor: 4.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.